Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1985-11-08
1988-11-08
Marantz, Sidney
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 424 8591, 424 9463, 424 9464, 4351722, 435188, 43524027, 435948, 436519, 436548, 530387, 530391, 530808, 935107, 935110, A61K 3747, A61K 3752, A61K 4902, G01N 33577
Patent
active
047833300
ABSTRACT:
An antibody reactive with activated human platelets, and substantially unreactive with resting human platelets, with the azurophilic granules of monocytes, and with granulocytes.
REFERENCES:
patent: 4486538 (1984-12-01), Bogoch
patent: 4536391 (1985-08-01), Miyazaki et al.
patent: 4564596 (1986-01-01), Maximenko et al.
S. B. Kadin et al., in J. J. Marchalonis et al. (Eds.) Antibody as a Tool, John Wiley & Sons, New York, 1982, pp. 457-460.
P. E. Stenberg et al., Journ. Cell Biol., 101, 880-886, 1985.
Nieuwenhuis et al. (1983) Thromb. Haemostasis 50:100.
McEver et al. (1983) Blood 62, Suppl. 1, 262.
McEver et al. (1984) J. Biol. Chem. 259 (15):9799.
Hsu-Lin et al. (1984) Fed. Proc. 43, 3078B.
Hsu-Lin et al. (1984) Blood 62, Suppl. 1, 257.
Furie Barbara C.
Furie Bruce E.
Marantz Sidney
New England Medical Center Hospitals Inc.
Saunders David A.
LandOfFree
Monoclonal antibodies to activated platelets does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies to activated platelets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to activated platelets will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-463242